Evidence map›Paper›PMID 24602920›Full record

SynthesisRheumatology (Oxford, England)2014

Reporting of patient-perceived impact of rheumatoid arthritis and axial spondyloarthritis over 10 years: a systematic literature review.

Laure Gossec, Francis Berenbaum, Pierre Chauvin, Karine Lamiraud, Francoise Russo-Marie, Jean-Michel Joubert, Alain Saraux

Abstract readComparative StudySystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Rheumatology (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laure GossecUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.UPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France. laure.gossec@psl.aphp.fr.
Francis BerenbaumUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.UPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.
Pierre ChauvinUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.
Karine LamiraudUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.UPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.
Francoise Russo-MarieUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.
Jean-Michel JoubertUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.
Alain SarauxUPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS), Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, UPMC Univ Paris 06, Department of Rheumatology, AP-HP, Saint Antoine Hospital, INSERM, UMRS 707, ESSEC Business School, Paris, THEMA, University of Cergy Pontoise, Cergy Pontoise, Fondation Arthritis, Neuilly, UCB Pharma, Colombes and Rheumatology Department, Cavale Blanche University Hospital and EA 2216, Université Bretagne Occidentale, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRA and axial SpA have an important impact on patients' lives. The objective of this study was to explore the reporting of different aspects of that impact in publications, with a focus on differences between diseases and over time.

methodsA systematic literature review retrieved all articles reporting on the life impact of RA or axial radiographic SpA in adults published within the last 10 years and issued from European research. The data were classified into physical impact (including pain, functional assessment and fatigue), psychological impact (including psychological distress and coping) and social impact (including relationships, family and social life). The number of articles published over time was analysed by linear regression.

resultsIn all, 1352 abstracts were screened and 149 publications (40,056 patients) were analysed: 129 articles (86.5%) concerned RA and 16 (10.7%) concerned axial SpA. The mean number of articles reporting on the physical aspects of impact was 11.4 (s.d. 4.8) per 2-year period, but increased more than 2-fold (from 7 articles in 2001-3 to 15 in 2010-11), in particular due to recent publications on fatigue, whereas the number of articles on psychological aspects [mean 12.4 (s.d. 4.0)] decreased markedly after 2006. Publications reporting on social aspects [mean 8.2 (s.d. 4.1)] remained globally stable.

conclusionIn the era of biologics, there is an interest in the patient-perceived life impact of RA and axial SpA in the European literature, but the impact of RA has been the subject of greater exploration. There are clearly trends over time in the reporting of impact.

Indexed as

Self ConceptArthritis, RheumatoidFatigueHumansLinear ModelsLongitudinal StudiesPainPrevalenceQuality of LifeSpondylarthritiscopingfatigueimpactpainquality of liferheumatoid arthritissocialspondyloarthritis

Identifiers

PMID24602920
PMCPMC4065006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.